Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.
Miguel Antonio Lasheras-PérezRodolfo David Palacios-DiazMonica Pozuelo-RuizIgnacio Torres-NavarroRafael Botella-EstradaMercedes Rodriguez-SernaPublished in: International journal of dermatology (2023)
Keyphrases